Hydroxysafflor yellow A could inhibit hepatocellular carcinoma through the inhibition of MMP-2, MMP-9, and p38MAPK signaling pathways in HepG2 cells (Zhang J. et al., 2019). This evidence concerns the gene MMP2 and hepatocellular carcinoma.